Quarter 2026/Q2
| Line item | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 |
|---|---|---|---|---|---|
| Free Cash Flow | $84.00M | $1.00M | $109.00M | $24.00M | $37.00M |
| -Change in Payables and Accrued Expense | $154.00M | $326.00M | -$53.00M | -$20.00M | -$38.00M |
| -Change in Inventory | -$216.00M | -$279.00M | -$40.00M | -$44.00M | $4.00M |
| -Change in Receivables | -$169.00M | -$249.00M | $77.00M | -$19.00M | $12.00M |
| Change in Working Capital | -$219.00M | -$238.00M | -$14.00M | -$81.00M | $1.00M |
| Other Non-Cash Items | $31.00M | $32.00M | $24.00M | $22.00M | $28.00M |
| Deferred Tax | $66.00M | $76.00M | $51.00M | $38.00M | $20.00M |
| Depreciation & Depletion & Amortization | $84.00M | $83.00M | $86.00M | $84.00M | $82.00M |
| Gain/Loss from Continuing Operations | $108.00M | -$41.00M | -$16.00M | -$11.00M | -$32.00M |
| Net Income from Continuing Operations | $148.00M | $196.00M | $113.00M | $88.00M | $36.00M |
| Net cash flow from continuing operations | $161.00M | $73.00M | $218.00M | $99.00M | $114.00M |
| Operating Cash Flow | $161.00M | $73.00M | $218.00M | $99.00M | $114.00M |
| -Change In Other Working Capital | $12.00M | -$36.00M | $2.00M | $2.00M | $23.00M |
| Net cash flow from investing | -$69.00M | -$68.00M | -$109.00M | -$69.00M | -$72.00M |
| Net Cash Flow from Continuing Investing Activities | -$69.00M | -$68.00M | -$109.00M | -$69.00M | -$72.00M |
| Effect of Exchange Rate Changes | -$1.00M | -$2.00M | $1.00M | $0.00 | $9.00M |
| Beginning Cash Balance | $143.00M | $120.00M | $122.00M | $133.00M | $118.00M |
| Net Change in Cash | $21.00M | $25.00M | -$3.00M | -$11.00M | $6.00M |
| Ending Cash Balance | $163.00M | $143.00M | $120.00M | $122.00M | $133.00M |
| Net Other Financing Charges | -$2.00M | $1.00M | $2.00M | -$1.00M | -$21.00M |
| Net Common Stock Issuance | -$20.00M | -$28.00M | -$40.00M | -$25.00M | -$35.00M |
| Net Issuance Payments Of Debt | -$49.00M | $47.00M | -$74.00M | -$15.00M | $20.00M |
| Financing Cash Flow | -$71.00M | $20.00M | -$112.00M | -$41.00M | -$36.00M |
| Net Business Purchase and Sale | $2.00M | – | $0.00 | $0.00 | $0.00 |
| Net Cash Flow from Continuing Financing Activities | -$71.00M | $20.00M | -$112.00M | -$41.00M | -$36.00M |
| Net PPE Purchase and Sale | -$71.00M | -$68.00M | -$108.00M | -$69.00M | -$73.00M |
| Net Other Investing Changes | – | – | -$1.00M | $0.00 | $1.00M |
No comments yet — be the first to weigh in on CSTM.